Experience
Completed transactions in MedTech, Life Sciences and Digital Health, from establishing Australian entities through to acquisition.
EXPERIENCE AND TRACK RECORD
We've been there through to exit
Our work is backed by experience across completed transactions in MedTech, Life Sciences and Digital Health. Some details are summarised for confidentiality.
Volpara Healthth
Mark Bouw joined the board of Volpara Health (ASX: VHT) in January 2022, including the Audit and Risk Committees, and was part of the exit strategy team.
Acquired by Lunit in an all-cash deal in May 2024
Theracell
Established Theracell's Australian entity, led and managed Theracell Labs Pty Ltd, and delivered its accounting, bookkeeping and compliance, risk management system, intercompany IP agreement and R&D program.
Acquired by Isto Biologics in April 2022
Biorez
Established Biorez's Australian entity, led and managed Biorez Pty Ltd, and delivered its accounting, bookkeeping and compliance, risk management system, intercompany IP agreement and R&D program.
Acquired by Conmed (NYSE: CNMD) in August 2022
Looking for Business Advisors & Accountants who know Life Sciences?
Tell us what stage your business is at and we'll tell you honestly how we can help.